REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/04/2026
Voltar para busca
Dado oficial do USPTO
RCT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
07/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
03/01/2017
Data de registro
06/04/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/04/2021
Última transação
07/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
15/10/2019
Primeiro uso no comércio
15/10/2019
Código do desenho
4
Tipo de titular
03
Localização do titular
Cambridge, MA, US
Examinador
VALLILLO, MELISSA C
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Rubius Therapeutics, Inc.
Representantes
Christina M. Licursi WOLF GREENFIELD & SACKS, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditionscancerinflammatory diseases and disordersautoimmune diseases and disordersmetabolic diseases and disordersgenetic diseases and disordersinfectious diseases and disorderscardiovascular diseases and disordersnone of the foregoing related chemical researchresearch services in connection with physics and engineering researchto photovoltaic installations
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/02/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
30/09/2020
GNFR
FINAL REFUSAL E-MAILED
30/09/2020
CNFR
SU - FINAL REFUSAL - WRITTEN
30/09/2020
MREI
NOTICE OF REINSTATEMENT E-MAILED
11/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2020
RGIA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
08/09/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
03/09/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2020
GNRT
NON-FINAL ACTION E-MAILED
13/02/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
13/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/01/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
28/01/2020
EX4G
SOU EXTENSION 4 GRANTED
28/01/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
28/01/2020
IUAF
USE AMENDMENT FILED
23/01/2020
EXT4
SOU EXTENSION 4 FILED
23/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
23/01/2020
EISU
TEAS STATEMENT OF USE RECEIVED
23/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/07/2019
EX3G
SOU EXTENSION 3 GRANTED
23/07/2019
EXT3
SOU EXTENSION 3 FILED
23/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
23/07/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/02/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/01/2019
EX2G
SOU EXTENSION 2 GRANTED
23/01/2019
EXT2
SOU EXTENSION 2 FILED
23/01/2019
EEXT
SOU TEAS EXTENSION RECEIVED
23/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/07/2018
EX1G
SOU EXTENSION 1 GRANTED
20/07/2018
EXT1
SOU EXTENSION 1 FILED
20/07/2018
EEXT
SOU TEAS EXTENSION RECEIVED
20/07/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/05/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/05/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
23/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/11/2017
PUBO
PUBLISHED FOR OPPOSITION
28/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/10/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
20/10/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/10/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
20/10/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2017
ALIE
ASSIGNED TO LIE
12/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/09/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/04/2017
GNRT
NON-FINAL ACTION E-MAILED
04/04/2017
CNRT
NON-FINAL ACTION WRITTEN
04/04/2017
DOCK
ASSIGNED TO EXAMINER
28/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RCT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.